KCNC4 as A Drug Target Or Biomarker (G3749)

Target Name: KCNC4

NCBI ID: G3749

KCNC4

KCNC4 as A Drug Target Or Biomarker

KCNC4 (Kv3.4) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the K+ channels subfamily, which plays a crucial role in the regulation of ion channels and their activities. KCNC4 is known to be involved in various physiological processes in the body, including neuronal signaling, muscle contractions, and blood pressure regulation.

The search for drug targets is an important area of research in the pharmaceutical industry, as it has the potential to lead to the development of new treatments for various diseases. One of the challenges in drug discovery is identifying potential targets that are druggable and have a clear mechanism of action. KCNC4 is an attractive target for drug research, as it has been shown to be involved in multiple signaling pathways and has been implicated in various diseases, including epilepsy, migraine, and heart disease.

Drug Targets

KCNC4 has been identified as a potential drug target due to its involvement in several signaling pathways that are involved in various physiological processes. One of the main drug targets for KCNC4 is its role in neuronal signaling. KCNC4 is known to be involved in the regulation of neuronal excitability, which is critical for the function of the nervous system.

Neurons are responsible for transmitting electrical signals throughout the body, and their activity is regulated by the release of various chemical messengers, including neurotransmitters. These messengers interact with specific receptors on the surface of the neuron, which in turn activate downstream signaling pathways. KCNC4 is involved in the regulation of these signaling pathways, including the regulation of neurotransmitter release and the modulation of ion channels in the neuron.

KCNC4 has also been shown to be involved in the regulation of muscle contractions. Muscle contractions are essential for maintaining posture, movement, and various other physiological functions. The regulation of muscle contractions is critical for maintaining muscle tone and resilience, and is also involved in the development of muscle weakness and wasting.

In addition to its role in neuronal and muscle signaling, KCNC4 has also been shown to be involved in the regulation of blood pressure. Blood pressure is critical for maintaining blood flow to the body's various tissues and is regulated by the contraction and relaxation of blood vessels. KCNC4 has been shown to be involved in the regulation of blood vessel diameter and blood pressure, which is critical for maintaining proper blood flow to the brain and other vital organs.

Biomarkers

The identification of biomarkers is an important step in drug discovery, as it allows researchers to measure the effectiveness of new treatments. KCNC4 has been shown to be involved in various physiological processes, including neuronal signaling, muscle contractions, and blood pressure regulation. As a result, KCNC4 has the potential to serve as a biomarker for a variety of diseases.

One of the main applications of KCNC4 as a biomarker is its potential to serve as a target for small molecules that can modulate its activity. This approach is based on the idea that the activity of KCNC4 can be modified by the addition of small molecules, such as drugs or natural compounds, which can alter its structure or function.

For example, various studies have shown that small molecules can modulate the activity of KCNC4 in a variety of ways. For example, some studies have shown that inhibitors of the action of a specific protein, known as Beclin-1, can modulate the activity of KCNC4. Other studies have shown that modulation of the activity of KCNC4 by small molecules can be used to confirm the involvement of this protein in various physiological processes.

Conclusion

KCNC4 is a protein that has been shown to be involved in various physiological processes in the body, including neuronal signaling, muscle contractions, and blood pressure regulation. As a result, it has the potential to serve as a drug target or biomarker for a variety of diseases. The identification of small molecules that can modulate the activity of

Protein Name: Potassium Voltage-gated Channel Subfamily C Member 4

Functions: This protein mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient

The "KCNC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets